rs7625439: What Your Genotype Means
The genetic marker rs7625439 is a common single-nucleotide polymorphism located in an intergenic region of the human genome. It has been cataloged across major population genetics projects such as dbSNP and gnomAD. Current scientific evidence links this variant only to limited, non-actionable statistical traits, meaning it does not carry direct clinical or medical consequences.
What each genotype means
Common genetic variant
This genotype represents the most common form of this variant observed in many global populations. Current scientific literature does not associate this specific genetic sequence with any established clinical health conditions or actionable traits.
This is a common genotype found across diverse global populations.
Common genetic variant
This genotype represents a heterozygous state for this variant. There is no current evidence in peer-reviewed research to suggest that carrying one copy of this allele results in any specific health-related phenotype or clinical outcome.
This is a common genotype found across diverse global populations.
Common genetic variant
This genotype represents the alternative homozygous state for this variant. It is considered a normal variation in the human genome and is not linked to any known disease risks or specific consumer health traits in current scientific databases.
This is a common genotype found across diverse global populations.
Genomic Location and Context
The variant designated rs7625439 is a single-nucleotide polymorphism (SNP) indexed in the National Center for Biotechnology Information's [dbSNP catalog](https://www.ncbi.nlm.nih.gov/snp/rs7625439). In human DNA, SNPs represent single base-pair substitutions that occur at specific genomic coordinates. This particular marker is classified as intergenic, meaning it resides in the non-coding regions between distinct protein-coding genes. Because it does not directly alter the amino acid sequence of an enzyme, receptor, or structural protein, intergenic variations typically have a lower likelihood of causing severe, disruptive health conditions. Instead, variants in these broad chromosomal stretches may function as benign natural variation, markers of ancestral lineage, or subtle long-range regulatory sequences. Modern genomic analyses routinely track such sites across the genome to map normal human diversity, evaluate population structure, and serve as baseline reference points when conducting association studies.
Biological Function and Gene Roles
Because rs7625439 sits within an intergenic space without an overlapping protein-coding gene annotation, it does not encode an identifiable biological product. In molecular genetics, the impact of non-coding markers often depends on whether they overlap with regulatory elements such as enhancers, promoters, silencers, or long non-coding RNAs that influence nearby or distant genes. In the case of rs7625439, functional assays and curated gene catalogs such as GenCC have not established a direct causal relationship between this base change and any specific physiological pathway. Rather than acting as a driver of cellular dysfunction, variations of this nature are frequently neutral inherited polymorphisms. Functional genomics research continues to evaluate intergenic regions to map chromatin conformation and epigenetic marks, but current evidence does not suggest that rs7625439 disrupts essential cellular functions or metabolic cascades.
Research Associations and Evidence Strength
In large-scale population surveys and genome-wide association studies cataloged in the [GWAS Catalog](https://www.ebi.ac.uk/gwas/search?query=rs7625439), rs7625439 displays very limited evidence of phenotypic impact. Variants cataloged in these efforts are evaluated through statistical correlations between allele frequencies and measured physiological or physical traits. For rs7625439, published findings do not demonstrate robust, independently replicated links to major clinical diseases, pathological syndromes, or pharmacogenomic outcomes. Any potential associations documented in exploratory studies represent minor statistical fluctuations rather than deterministic biological drivers. Repositories such as ClinVar do not list actionable pathological submissions for this marker, and pharmacogenetic resources like PharmGKB do not report drug-response implications. Consequently, genomic scientists classify the overall evidence base for rs7625439 as limited and observational, reflecting normal human diversity rather than diagnostic relevance.
Global Population Frequencies
Data from large-scale reference databases, such as the 1000 Genomes Project and gnomAD, show that rs7625439 is a common variant present across multiple ancestral groups. Single-nucleotide polymorphisms that have persisted throughout human evolutionary history often reach relatively high frequencies across diverse continental populations, including African, European, East Asian, and admixed groups. While specific minor allele frequencies can fluctuate between regional populations due to genetic drift and historical demographic bottlenecks, both standard alleles remain widely distributed globally. Because this variant is common in healthy reference cohorts, its widespread presence supports the consensus that it is a benign polymorphism that does not reduce evolutionary fitness or cause congenital abnormalities. Researchers frequently employ such common SNPs in population genetics to model ancestral lineages and perform statistical imputation across broader genomic regions.
What You Can and Cannot Conclude
Discovering your rs7625439 genotype through a consumer DNA test or sequencing panel provides insight into your unique genetic sequence, but it carries no clinical or diagnostic weight. You cannot conclude that carrying a specific allele elevates or lowers your risk for major diseases, nor does it provide a basis for altering medical treatments, daily nutrition, or lifestyle routines. Because scientific evidence linking this marker to tangible health traits is strictly limited, commercial interpretations attempting to assign profound health implications to rs7625439 are unsupported by peer-reviewed research. If you are reviewing genetic data with an eye toward understanding personal health, cardiovascular risk, or drug metabolism, focus on well-validated variants reviewed by bodies like CPIC or ACMG. Always consult a licensed genetic counselor, physician, or clinical pharmacist before drawing any healthcare conclusions from raw genetic data.
How common is this variant?
The rs7625439 variant is common across global populations, with both alleles well-represented in reference datasets such as gnomAD and the 1000 Genomes Project.
Frequently asked questions
What does my rs7625439 genotype mean for my daily health?
Your rs7625439 genotype has no known impact on your daily health, wellness, or physical fitness. Because it is an intergenic marker with limited evidence linking it to complex traits, carrying any combination of its alleles is considered part of normal human diversity.
Is rs7625439 associated with any specific disease?
Current research indexed in medical databases like ClinVar and PubMed shows no established or replicated causal link between rs7625439 and specific human diseases. Any weak statistical findings in population studies remain exploratory and lack clinical significance.
Does rs7625439 affect how I metabolize medications?
No, rs7625439 is not recognized as a pharmacogenomic marker by CPIC or PharmGKB. It does not dictate how your body processes prescription medications, and dosing decisions should never be altered based on this variant.
Why is rs7625439 included on consumer DNA testing chips?
Consumer genotyping platforms often include hundreds of thousands of common SNPs like rs7625439 to serve as genomic landmarks. These markers help algorithms accurately align raw data, infer ancestral heritage, and perform statistical imputation across adjacent DNA regions.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7625439?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
This variant in the CYP1A2 gene influences the hepatic metabolism rate of caffeine and is a key marker for individual differences in caffeine clearance.
Intronic marker associated with CYP1A2 enzyme activity and caffeine metabolism rates.
Modulates CYP1A2 inducibility affecting the rate of caffeine metabolism and clearance.
Regulatory variant associated with CYP1A2 enzyme activity, influencing the rate of caffeine metabolism and habitual coffee consumption.
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.
Intronic regulatory polymorphism associated with CYP1A2 inducibility and differences in dietary caffeine metabolism rates.